Pharma Insider Sells 4,772 Shares as 2025 Revenue Hits $883M
A high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
Identify smart fund options for retirement diversification, focusing on balance, risk management, and practical allocation ideas for real-world use.
24,189 articlesA high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
Energy Fuels stock is catching a strong bid as investors react to fresh progress in its rare-earths unit and a broade...
A top financial executive recently disclosed a share sale at Robinhood. This article breaks down what the move means,...
The VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
Gold traders have a reason to pay attention. JPMorgan's latest forecasts bullish view supports a patient, rule-based ...
When a founder sells a large chunk of stock, it can raise questions for investors. This article explains what best bu...
A long-running insurer broker, founded in 1941, has quietly raised its dividends for decades and now offers a compell...
Oil jumps to $100 per barrel, sparking renewed interest in energy income strategies. This report breaks down XOMO, ML...
As AI-driven data centers swell, electricity bills could rise in parts of the U.S. Utilities may lean on natural gas ...
The FDA recently approved fruit-flavored e-cigarettes, prompting scrutiny from health advocates and investors. A new ...
When a global star faces health setbacks, a comeback isn’t just about a setlist. This story looks at Lewis Capaldi’s ...
Imagine turning a modest $100 monthly investment into a meaningful future. This guide breaks down how a stock that co...